Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Investment Tools And Research To Help Make You A More Confident And Profitable Trader. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Gyre Therapeutics Inc (GYRE)

Gyre Therapeutics Inc (GYRE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Gyre Therapeutics Inc 12770 HIGH BLUFF DRIVE SUITE 150 SAN DIEGO CA 92130 USA

www.gyretx.com P: 619-949-3681

Description:

Gyre Therapeutics Inc. is a biotechnology company. It focused on organ fibrosis and inflammatory diseases. The company's product pipeline primarily includes F573, F528 and F230. Gyre Therapeutics Inc., formerly known as Catalyst Biosciences Inc., is based in United States.

Key Statistics

Overview:

Market Capitalization, $K 1,340,287
Enterprise Value, $K 1,371,307
Shares Outstanding, K 85,423
Annual Sales, $ 113,450 K
Annual Net Income, $ -92,930 K
Last Quarter Sales, $ 113,450 K
Last Quarter Net Income, $ -89,150 K
EBIT, $ -176,040 K
EBITDA, $ -174,930 K
60-Month Beta 2.13
% of Insider Shareholders 2.92%
% of Institutional Shareholders 23.99%
Float, K 82,929
% Float 97.08%
Short Volume Ratio 0.68

Growth:

1-Year Return 380.97%
3-Year Return -74.98%
5-Year Return -87.65%
5-Year Revenue Growth 1,134,400.00%
5-Year Earnings Growth 100.67%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings -0.60 on 10/26/23
Latest Earnings Date 05/20/24
Earnings Per Share ttm -3.30
EPS Growth vs. Prev Qtr 42.86%
EPS Growth vs. Prev Year 75.00%
Annual Dividend Yield 0.00%
Most Recent Dividend 0.569 on 08/20/15
Dividend Payout Ratio 106.21%
Most Recent Split 1-15 on 10/31/23

GYRE Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % 0.00%
Return-on-Assets % -228.91%
Profit Margin % -81.91%
Debt/Equity 0.00
Price/Sales 11.16
Price/Cash Flow 59.58
Price/Book 81.38
Book Value/Share 1.02
Interest Coverage -0.03

GYRE Dividends

Date Value
08/20/15 $0.5690
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar